Intralesional chemotherapy for head and neck carcinoma: A review of the literature

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 97, Issue 3, 2004, Pages 307-311

  Barasch, Andrei ^a   Epstein, Joel B ^b,c   Foong, W Choong ^a   Clayman, Lewis ^a  

^a UNIVERSITY OF DETROIT MERCY   (United States)

^b Dept of Oral Med and Diagn Sci

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; PLATINUM DERIVATIVE; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CYTOTOXICITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG POTENCY; DRUG RELEASE; DRUG TISSUE LEVEL; DRUG TOLERABILITY; GEL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INJECTION; KAPOSI SARCOMA; MEDICAL LITERATURE; MOUTH CARCINOMA; NONHUMAN; PAIN; POPULATION RESEARCH; REVIEW; SIDE EFFECT; SKIN INFECTION; SKIN MANIFESTATION; SKIN NECROSIS; SKIN ULCER; TOXICITY; TREATMENT OUTCOME;

EID: 1542358954     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2003.12.016     Document Type: Article

References (35)

1. Barasch A., Morse D.E., Krutchkoff D.J., Eisenberg E. Smoking, gender and age as risk factors for site-specific intraoral squamous cell carcinoma. Cancer. 73:1994;509-513.
2. Fioretti F., Bosetti C., Tavani A., Franceschi S., La Vechia C. Risk factors for oral and pharyngeal cancer in never smokers. Oral Oncol. 35:1999;375-378.
3. Llewellyn C.D., Johnson N.W., Warnakulasuriya K.A.A.S. Risk factors for squamous cell carcinoma of the oral cavity in young people - a comprehensive literature review. Oral Oncol. 37:2001;401-418.
4. Miller C.S., Johnstone B.M. Human papilloma virus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 91:2001;622-635.
5. Argiris A. Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol. 14:2002;323-329.
6. Posner M.R., Colevas A.D., Tishler R.B. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck. Semin Oncol. 27:2000;13-24.
7. Adelstein D.J. Integration of chemotherapy into the definitive management of squamous cell head and neck cancer. Curr Oncol Rep. 1:1999;97-98.
8. Bourhis J., Eschwege F. Radiotherapy-chemotherapy combination in head and neck squamous cell carcinoma: overview of randomized trials. Anticancer Res. 16:1996;2397-2402.
9. Brizel D.M. Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma. Semin Radiat Oncol. 8:1998;237-246.
10. Lamont E.B., Vokes E.E. Chemotherapy in the management of squamous cell carcinoma of the head and neck. Lancet Oncol. 2:2001;261-269.
11. Lilly S.G., Lilly G.E., Marek C.L. Medical oncology in the management of head and neck cancers. Otolaryngol Clin North Am. 31:1998;881-905.
12. Pignon J.P., Bourhis J., Domenge C., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet. 355:2000;767-768.
13. Zidan J., Kuten E., Rosenblatt E., Robinson E. Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer. Oral Oncol. 33:1997;129-135.
14. Feher O., Martins S.J., Lima C.A., Salvajoli J.V., Simpson A.J., Kowalski L.P. Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of the head and neck. Head Neck. 24:2002;228-235.
15. Maipang T., Watanaarepornchai S., Panjapiyakul C., Totemchokchyakarn P. Cisplatinum-epirubicin chemotherapy for advanced unresectable squamous cell carcinoma of the head and neck. Head Neck. 15:1993;109-114.
16. Duvillard C., Benoit L., Moretto P., Beltramo J.L., Brunet-Lecomte P., Correira M., et al. Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors. Int J Cancer. 81:1999;779-784.
17. Kraus S., Miller B.H., Swinehart J.M., Shavin J.S., Georgouras K.E., Jenner D.A., et al. Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 38:1998;438-442.
18. Malhotra H., Plosker G.L. Cisplatin/epinephrine injectable gel. Drugs Aging. 18:2001;787-793.
19. Vogl T.J., Engelmann K., Mack M.G., Straub S.G., Zangos S., Woitaschek D., et al. CT-guided intratumoural administration of cisplatin/epinephrine gel for treatment of malignant liver tumours. Br J Cancer. 86:2002;524-529.
20. Wenig B.L., Werner J.A., Castro D.J., Sridhar K.S., Garewal H.S., Kehrl W., et al. The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 128:2002;880-885.
21. Epstein J.B. Management of intraoral Kaposi's sarcoma and a proposal for clinical staging. Oral Dis. 3:1997;S124-S128.
22. Flaitz C.M., Nichols C.M., Hicks M.J. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS. Oral Oncol Eur J Cancer. 31B:1995;280-285.
23. Ramirez-Amador V., Esquivel-Pedraza L., Lozada-Nur F., De la Rosa-Garcia E., Volkow-Fernandez P., Suchil-Bernal L., et al. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma: a double blind, randomized clinical trial. Oral Oncol. 38:2002;460-467.
24. Clayman G.L., Dreiling L.K. Injectable modalities as local and regional strategies for head and neck cancer. Hematol Oncol Clin North Am. 13:1999;787-810.
25. Wilson W.R., Siegel R.S., Harisiadis L.A., Davis D.O., Nguyen H.H., Bank W.O. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 127:2001;809-812.
26. Burris H.A. 3rd, Vogel C.L., Castro D., Mishra L., Schwarz M., Spencer S., et al. Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg. 118:1998;496-503.
27. Miller B.H., Shavin J.S., Cognetta A., Taylor R.J., Salasche S., Korey A., et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. J Am Acad Dermatol. 36:1997;72-77.
28. Miller C.L., Templeton R.S., Karpinski L. Successful treatment of oral squamous cell carcinoma with intralesional fluorouracil in a Malayan tapir (Tapirus indicus). J Zoo Wildl Med. 31:2000;262-264.
29. Smith J.P., Kanekal S., Patawaran M.B., Chen J.Y., Jones R.E., Orenberg E.K., et al. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts. Cancer Chemother Pharmacol. 44:1999;267-274.
30. Sileni V.C., Fosser V., Maggian P., Padula E., Beltrame M., Nicolini M., et al. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer. Cancer Chemother Pharmacol. 30:1992;221-225.
31. Kovacs A.F., Turowski B., Ghahremani M.T., Loitz M. Intraarterial chemotherapy as neoadjuvant treatment for oral cancer. J Craniomaxillofac Surg. 27:1999;302-307.
32. Robbins K.T., Kumar P., Regine W.F., Wong F.S., Weir A.B. 3rd, Flich P., et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys. 38:1997;263-271.
33. Furutani K., Fuwa N., Kodaira T., Matsumoto A., Kamata M., Tachibana H., et al. Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol. 38:2002;145-152.
34. Gemmete J.J. Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc Interv Radiol. 14:2003;743-748.
35. Galmarini F.C., Galmarini C.M., Sarchi M.I., Abulafia J., Galmarini D. Heterogeneous distribution of tumor blood supply affects the response to chemotherapy in head and neck cancers. Microcirculation. 7:2000;405-410.